BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 347784)

  • 1. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
    Kozma D; Mihalik P; Schaff Z; Lapis K
    Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isoniazid-rifampicin: a model for hepatotoxicity and for bibliographic Anglomania].
    Toulet J; Viteau JM
    Gastroenterol Clin Biol; 1978; 2(8-9):756-7. PubMed ID: 361483
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nature of the hepatotoxic action of isoniazid (review of the literature)].
    Skakun NP; Shman'ko VV
    Vrach Delo; 1984 Jan; (1):49-52. PubMed ID: 6367216
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
    Kameda K; Kawabata S; Shirai S
    Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].
    Volosevich GV
    Probl Tuberk; 1989; (9):72-3. PubMed ID: 2587561
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoniazid-rifampicin-induced submassive hepatic necrosis.
    Kasantikul V
    J Med Assoc Thai; 1989 Jan; 72(1):56-8. PubMed ID: 2723568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
    Skakun NP; Shman'ko VV
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 15. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isoniazid-rifampicin: an exemplary hepatotoxicity].
    Berthelot P
    Gastroenterol Clin Biol; 1978 Feb; 2(2):129-32. PubMed ID: 640330
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity of isoniazid and rifampin in children.
    Rugmini PS; Mehta S
    Indian Pediatr; 1984 Feb; 21(2):119-26. PubMed ID: 6469294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.